
Michael Burgess, MD @michaelcburgess
I agree with @ScottGottlieb the result of H.R. 3 will be #FewerCures. This is why I support #MoreCures with H.R. 19 a bill that contains products of the bipartisan work of @HouseCommerce. — PolitiTweet.org
The Wall Street Journal @WSJ
From @WSJopinion: The high-cost drugs that lawmakers target are often the most innovative and potentially transform… https://t.co/zaMbDhhsCD